Abstract Topics

Abstract Topics

• Antimicrobials
  • Novel antimicrobial treatments 
  • Resistance 
  • Pharmacology
  • Antibiotic Stewardship
• Public health and epidemiology (only non SARS-CoV2 content)
  • Population studies and surveillance
  • Modelling studies
• Vaccines (only non SARS-CoV2 content)
  • Vaccine development (phase 1-2) –  viral
  • Vaccine development (phase 1-2)  – bacterial and all non-viral
  • Vaccine efficacy (phase 3) and effectiveness – viral
  • Vaccine efficacy (phase 3) and effectiveness – bacterial and all non-viral
  • Vaccine safety (post licensure)
  • Vaccine hesitancy
• Immunology & compromised host
  • Host-pathogen interaction
  • Host response diagnostics and imaging
  • Severe/systemic fungal infections
  • Infections in immunocompromised/immunodeficient patients
• Global health
  • Zoonosis, vector-borne and emerging infections
  • Tropical/parasite infections & travel medicine
  • Refugees and migrants
• Infections in early life
  • Congenital and perinatal infections
  • Neonatal sepsis
• Non-respiratory infections
  • Gastrointestinal infections – Hepatitis
  • Urogenital infections
  • CNS infections
  • Sepsis, systemic and multi-organ infections
  • Skeletal infections
  • Skin Infections
  • STDs
• Respiratory infections (only non-SARS-CoV2 content)
  • Viral respiratory infections 
  • Bacterial pneumonia
  • ENT infections
• Mycobacteria and retroviruses
  •  Tuberculosis and other mycobacterial infections
  • HIV/AIDS
• Digital tools and machine learning
  • Decision support tools 
  • Artificial intelligence in microbiology and radiology
  • Telemedicine
• Diagnostics and biomarkers
• Health associated infections, infection prevention and control
• COVID 19 and MIS-C
• Microbiome
• Prolonged/recurrent fever
• Other